Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs.

Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

We sat down with Dr. Bob Harari, a renowned biomedical scientist, surgeon, and entrepreneur. He is the Founder, Chairman, and CEO of Celularity, a biotechnology company leading the next evolution in cellular medicine. Dr. Hariri pioneered the use of stem cells to treat a range of life-threatening human diseases and continues today to make transformative contributions in the fields of immuno-oncology and cell therapeutics along with tissue engineering and functional regeneration. 

Dr. Hariri is widely acknowledged for his discovery of pluripotent stem cells derived from the human placenta, and as a member of the team that discovered the physiological activities of tumor necrosis factor (TNF). He holds over 150 issued and pending patents for discoveries including placenta-derived stem cells, which Nature recognized as one of the ten most important patent estates in the field. Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, and after its acquisition by Celgene Corporation, served as CEO of Celgene Cellular Therapeutics. Dr. Hariri also co-founded the genomic-based health intelligence company, Human Longevity, Inc.

Podcast Highlights:

• 
  
• Introduction & Dr. Bob Harari’s Research (1:00): Dr. Harari’s background and journey to longevity science.
  
• Placental Stem Cells (04:30): Advantages of using placental-derived stem cells and their ethical considerations.
  
• Universal Donor Tissue (10:05): Concept of the placenta as a universal donor tissue is explored, highlighting its potential in cellular therapies.
  
• Genetic Modification (12:40): Process of genetic modification in stem cells and their natural intelligence.
  
• Chimerism (20:35): The potential therapeutic benefits of chimerism in cellular medicine are discussed.
  
• Adult Stem Cell Banking (24:18): Cellularity’s adult stem cell banking program and its value for future treatments.
  
• Future of Stem Cell Medicine (36:40): A vision of stem cell medicine in 10 years, including potential treatments for cancer, autoimmune diseases, and aging-related conditions.
  

Social Media:

• 
  
• Dr. Bob Hariri’s Instagram: https://www.instagram.com/drbobhariri/?hl=en 
  
• Dr. Bob Hariri’s LinkedIn: https://www.linkedin.com/in/bob-hariri-md-phd-3654b239/ 
  

Other Links/Mentions/Resources:

• 
  
• Cellularity’s official website: https://www.cellularity.com/ 
  
• National Institutes of Health (NIH) information on stem cells: https://stemcells.nih.gov/ 
  
• FDA resources: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products 
  
• Nature article on chimerism: https://www.nature.com/articles/d41586-021-01001-2 
  
• The American Society for Gene and Cell Therapy’s patient education page: https://asgct.org/education 
  

Show Credits:

This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels:

• 
  
• X: @KCSAPodcastLabs
  
  
  
• Instagram: @KCSAPodcastLabs
  
  
  
• LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/